Zacks Investment Research Research Analysts Lift Earnings Estimates for CAS Medical Systems Inc. (CASM)
CAS Medical Systems Inc. (NASDAQ:CASM) – Zacks Investment Research lifted their FY2016 earnings estimates for CAS Medical Systems in a report issued on Tuesday. Zacks Investment Research analyst B. Marckx now anticipates that the firm will post earnings per share of ($0.24) for the year, up from their prior forecast of ($0.25). Zacks Investment Research also issued estimates for CAS Medical Systems’ FY2017 earnings at ($0.16) EPS and FY2018 earnings at ($0.06) EPS.
CAS Medical Systems (NASDAQ:CASM) opened at 1.73 on Friday. CAS Medical Systems has a 1-year low of $1.37 and a 1-year high of $2.15. The stock has a 50 day moving average of $1.70 and a 200-day moving average of $1.77. The firm’s market capitalization is $46.41 million.
About CAS Medical Systems
CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales.
Receive News & Stock Ratings for CAS Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems Inc. and related stocks with our FREE daily email newsletter.